Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s both cost-effective and life-saving.

Rise in drug pricing | Image Credit: Alex Puhovoy - stock.adobe.com

Medicare Inflation Rebates Show Limited Impact on Drug Price Trends

By Brooke McCormick

July 14th 2025

Medicare inflation rebates fail to curb rising drug prices, highlighting the need for further policy action to control costs.

Medicaid | Image credit: Andrii - stock.adobe.com

Experts Highlight Consequences of Medicaid Rollbacks Due to Budget Bill

By Julia Bonavitacola

July 10th 2025

A webinar held by KFF on July 9 emphasized the immediate effects of the new budget bill, highlighting the impacts on Medicaid and health spending in the next decade.

While accommodations can improve quality of life for patients with DMD and foster independence, the costs of home and ve modifications fall mostly on the families of patients. | Image credit: Nadzeya - stock.adobe.com

Accommodations as DMD Progresses Incur Substantial Household Costs

By Rose McNulty

July 10th 2025

Families caring for individuals with Duchenne muscular dystrophy (DMD) face significant financial burdens from necessary home and vehicle modifications to enhance quality of life.

Insurance gaps | Image Credit: iQoncept-stock.adobe.com

Insurance Gaps Threaten Cancer Treatment Success

By Maggie L. Shaw

July 7th 2025

Access to and affordability of immune checkpoint inhibitors, which can be lifesaving if patients receive them on time and under optimal circumstances, continue to top the list of reasons behind outcomes disparities for patients who have private insurance vs those who remain uninsured.

...

90 91 92 93 94

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions